{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T21:00:18Z","timestamp":1767992418026,"version":"3.49.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,7,3]],"date-time":"2014-07-03T00:00:00Z","timestamp":1404345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1038\/leu.2014.205","type":"journal-article","created":{"date-parts":[[2014,7,3]],"date-time":"2014-07-03T06:41:03Z","timestamp":1404369663000},"page":"297-303","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Genomic profiling of thousands of candidate polymorphisms predicts risk of relapse in 778 Danish and German childhood acute lymphoblastic leukemia patients"],"prefix":"10.1038","volume":"29","author":[{"given":"A","family":"Weso\u0142owska-Andersen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Borst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M D","family":"Dalgaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K K","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P S","family":"Wehner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T F","family":"\u00d8rntoft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Nordentoft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Koehler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C R","family":"Bartram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Schrappe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Sicheritz-Ponten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Gautier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Marquart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H O","family":"Madsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Brunak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Stanulla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Schmiegelow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,7,3]]},"reference":[{"key":"BFleu2014205_CR1","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1001\/jama.293.12.1485","volume":"293","author":"M Stanulla","year":"2005","unstructured":"Stanulla M, Schaeffeler E, Flohr T, Cario G, Schrauder A, Zimmermann M et al. Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia. JAMA 2005; 293: 1485\u20131489.","journal-title":"JAMA"},{"key":"BFleu2014205_CR2","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1097\/MPH.0b013e3181868570","volume":"30","author":"ML Davidsen","year":"2008","unstructured":"Davidsen ML, Dalhoff K, Schmiegelow K . Pharmacogenetics influence treatment efficacy in childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol 2008; 30: 831\u2013849.","journal-title":"J Pediatr Hematol Oncol"},{"key":"BFleu2014205_CR3","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1182\/blood-2012-05-378943","volume":"120","author":"CH Pui","year":"2012","unstructured":"Pui CH, Mullighan CG, Evans WE, Relling MV . Pediatric acute lymphoblastic leukemia: where are we going and how do we get there? Blood 2012; 120: 1165\u20131174.","journal-title":"Blood"},{"key":"BFleu2014205_CR4","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/01.mph.0000212972.90877.28","volume":"28","author":"E Forestier","year":"2006","unstructured":"Forestier E, Schmiegelow K . The incidence peaks of the childhood acute leukemias reflect specific cytogenetic aberrations. J Pediatr Hematol Oncol 2006; 28: 486\u2013495.","journal-title":"J Pediatr Hematol Oncol"},{"key":"BFleu2014205_CR5","doi-asserted-by":"publisher","first-page":"2984","DOI":"10.1182\/blood-2007-09-114082","volume":"111","author":"SM Davies","year":"2008","unstructured":"Davies SM, Borowitz MJ, Rosner GL, Ritz K, Devidas M, Winick N et al. Pharmacogenetics of minimal residual disease response in children with B-precursor acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood 2008; 111: 2984\u20132990.","journal-title":"Blood"},{"key":"BFleu2014205_CR6","doi-asserted-by":"publisher","first-page":"4752","DOI":"10.1182\/blood-2004-11-4544","volume":"105","author":"JC Rocha","year":"2005","unstructured":"Rocha JC, Cheng C, Liu W, Kishi S, Das S, Cook EH et al. Pharmacogenetics of outcome in children with acute lymphoblastic leukemia. Blood 2005; 105: 4752\u20134758.","journal-title":"Blood"},{"key":"BFleu2014205_CR7","doi-asserted-by":"publisher","first-page":"4671","DOI":"10.1182\/blood-2010-01-256958","volume":"115","author":"J Gregers","year":"2010","unstructured":"Gregers J, Christensen IJ, Dalhoff K, Lausen B, Schroeder H, Rosthoej S et al. The association of reduced folate carrier 80G>A polymorphism to outcome in childhood acute lymphoblastic leukemia interacts with chromosome 21 copy number. Blood 2010; 115: 4671\u20134677.","journal-title":"Blood"},{"key":"BFleu2014205_CR8","doi-asserted-by":"publisher","first-page":"4197","DOI":"10.1182\/blood-2012-07-440107","volume":"120","author":"JJ Yang","year":"2012","unstructured":"Yang JJ, Cheng C, Devidas M, Cao X, Campana D, Yang W et al. Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemia. Blood 2012; 120: 4197\u20134204.","journal-title":"Blood"},{"key":"BFleu2014205_CR9","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/leu.2011.32","volume":"25","author":"A Wesolowska","year":"2011","unstructured":"Wesolowska A, Dalgaard MD, Borst L, Gautier L, Bak M, Weinhold N et al. Cost-effective multiplexing before capture allows screening of 25\u2009000 clinically relevant SNPs in childhood acute lymphoblastic leukemia. Leukemia 2011; 25: 1001\u20131006.","journal-title":"Leukemia"},{"key":"BFleu2014205_CR10","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/leu.2009.251","volume":"24","author":"K Schmiegelow","year":"2010","unstructured":"Schmiegelow K, Forestier E, Hellebostad M, Heyman M, Kristinsson J, Soderhall S et al. Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia. Leukemia 2010; 24: 345\u2013354.","journal-title":"Leukemia"},{"key":"BFleu2014205_CR11","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/leu.2008.5","volume":"22","author":"T Flohr","year":"2008","unstructured":"Flohr T, Schrauder A, Cazzaniga G, Panzer-Grumayer R, van dV V, Fischer S et al. Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia. Leukemia 2008; 22: 771\u2013782.","journal-title":"Leukemia"},{"key":"BFleu2014205_CR12","doi-asserted-by":"publisher","first-page":"3206","DOI":"10.1182\/blood-2009-10-248146","volume":"115","author":"V Conter","year":"2010","unstructured":"Conter V, Bartram CR, Valsecchi MG, Schrauder A, Panzer-Grumayer R, Moricke A et al. Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study. Blood 2010; 115: 3206\u20133214.","journal-title":"Blood"},{"key":"BFleu2014205_CR13","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559\u2013575.","journal-title":"Am J Hum Genet"},{"key":"BFleu2014205_CR14","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/nature09298","volume":"467","author":"DM Altshuler","year":"2010","unstructured":"Altshuler DM, Gibbs RA, Peltonen L, Altshuler DM, Gibbs RA, Peltonen L et al. Integrating common and rare genetic variation in diverse human populations. Nature 2010; 467: 52\u201358.","journal-title":"Nature"},{"key":"BFleu2014205_CR15","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1111\/biom.12009","volume":"69","author":"J Besag","year":"2013","unstructured":"Besag J, Mondal D . Exact goodness-of-fit tests for Markov chains. Biometrics 2013; 69: 488\u2013496.","journal-title":"Biometrics"},{"key":"BFleu2014205_CR16","doi-asserted-by":"publisher","first-page":"D472","DOI":"10.1093\/nar\/gkt1102","volume":"42","author":"D Croft","year":"2014","unstructured":"Croft D, Mundo AF, Haw R, Milacic M, Weiser J, Wu G et al. The Reactome pathway knowledgebase. Nucleic Acids Res 2014; 42: D472\u2013D477.","journal-title":"Nucleic Acids Res"},{"key":"BFleu2014205_CR17","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/0005-2795(75)90109-9","volume":"405","author":"BW Matthews","year":"1975","unstructured":"Matthews BW . Comparison of the predicted and observed secondary structure of T4 phage lysozyme. Biochim Biophys Acta 1975; 405: 442\u2013451.","journal-title":"Biochim Biophys Acta"},{"key":"BFleu2014205_CR18","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/978-1-62703-435-7_20","volume":"1015","author":"CF Thorn","year":"2013","unstructured":"Thorn CF, Klein TE, Altman RB . PharmGKB: the Pharmacogenomics Knowledge Base. Methods Mol Biol 2013; 1015: 311\u2013320.","journal-title":"Methods Mol Biol"},{"key":"BFleu2014205_CR19","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nrc706","volume":"2","author":"MM Gottesman","year":"2002","unstructured":"Gottesman MM, Fojo T, Bates SE . Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2002; 2: 48\u201358.","journal-title":"Nat Rev Cancer"},{"key":"BFleu2014205_CR20","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/j.1742-4658.2010.07919.x","volume":"278","author":"C Gialeli","year":"2011","unstructured":"Gialeli C, Theocharis AD, Karamanos NK . Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J 2011; 278: 16\u201327.","journal-title":"FEBS J"},{"issue":"Suppl 1","key":"BFleu2014205_CR21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s12307-009-0022-y","volume":"2","author":"Y Sato","year":"2009","unstructured":"Sato Y, Goto Y, Narita N, Hoon DS . Cancer cells expressing Toll-like receptors and the tumor microenvironment. Cancer Microenviron 2009; 2 (Suppl 1): 205\u2013214.","journal-title":"Cancer Microenviron"},{"key":"BFleu2014205_CR22","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1042\/BSR20120055","volume":"32","author":"RG Correa","year":"2012","unstructured":"Correa RG, Milutinovic S, Reed JC . Roles of NOD1 (NLRC1) and NOD2 (NLRC2) in innate immunity and inflammatory diseases. Biosci Rep 2012; 32: 597\u2013608.","journal-title":"Biosci Rep"},{"key":"BFleu2014205_CR23","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/ejh.12097","volume":"90","author":"N Toft","year":"2013","unstructured":"Toft N, Birgens H, Abrahamsson J, Bernell P, Griskevicius L, Hallbook H et al. Risk group assignment differs for children and adults 1-45yr with acute lymphoblastic leukemia treated by the NOPHO ALL-2008 protocol. Eur J Haematol 2013; 90: 404\u2013412.","journal-title":"Eur J Haematol"},{"key":"BFleu2014205_CR24","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ejca.2013.09.027","volume":"50","author":"TL Frandsen","year":"2014","unstructured":"Frandsen TL, Heyman M, Abrahamsson J, Vettenranta K, aasberg A, Vaitkeviciene G et al. Complying with the European Clinical Trials Directive while surviving the administrative pressure\u2014an alternative approach to toxicity registration in a cancer trial. Eur J Cancer 2014; 50: 251\u2013259.","journal-title":"Eur J Cancer"},{"key":"BFleu2014205_CR25","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/ejh.12243","volume":"92","author":"B Lund","year":"2014","unstructured":"Lund B, Wesolowska-Andersen A, Lausen B, Borst L, Rasmussen KK, Muller K et al. Host genome variations and risk of infections during induction treatment for childhood acute lymphoblastic leukaemia. Eur J Haematol 2014; 92: 321\u2013330.","journal-title":"Eur J Haematol"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/leu2014205.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/leu2014205","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/leu2014205.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T18:04:44Z","timestamp":1684433084000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2014205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,3]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["BFleu2014205"],"URL":"https:\/\/doi.org\/10.1038\/leu.2014.205","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,3]]},"assertion":[{"value":"16 April 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}